Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Julia Deri"'
Autor:
Istvan Petak, Maud Kamal, Anna Dirner, Ivan Bieche, Robert Doczi, Odette Mariani, Peter Filotas, Anne Salomon, Barbara Vodicska, Vincent Servois, Edit Varkondi, David Gentien, Dora Tihanyi, Patricia Tresca, Dora Lakatos, Nicolas Servant, Julia Deri, Pauline du Rusquec, Csilla Hegedus, Diana Bello Roufai, Richard Schwab, Celia Dupain, Istvan T. Valyi-Nagy, Christophe Le Tourneau
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
Abstract Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic alterations of multiple driver genes
Externí odkaz:
https://doaj.org/article/25368c6568c249e3961734d462c71641
Autor:
Odette Mariani, Edit Várkondi, Ivan Bièche, István Peták, Csilla Hegedüs, David Gentien, Diana Bello Roufai, Anne Vincent Salomon, Julia Deri, Christophe Le Tourneau, Pauline du Rusquec, Nicolas Servant, Barbara Vodicska, Richard Schwab, Vincent Servois, Dóra Lakatos, Dora Tihanyi, Róbert Dóczi, Anna Dirner, Celia Dupain, P. Filotas, Maud Kamal, István Vályi-Nagy, P. Tresca
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-11 (2021)
NPJ Precision Oncology
NPJ Precision Oncology
Precision oncology is currently based on pairing molecularly targeted agents (MTA) to predefined single driver genes or biomarkers. Each tumor harbors a combination of a large number of potential genetic alterations of multiple driver genes in a comp
Autor:
Istvan Petak, Barbara Vodicska, Eniko Kispeter, Robert Doczi, Dora Tihanyi, Dora Lakatos, Anna Dirner, Matyas Vidermann, Reka Szalkai-Denes, Julia Deri, Maud Kamal, Richard Schwab, Christophe Le Tourneau
Publikováno v:
Journal of Clinical Oncology. 40:e13616-e13616
e13616 Background: Several molecularly targeted agents (MTA) are registered in the same indication, even in the same line, to treat gastrointestinal (GI) cancers. Comprehensive molecular profiling is readily available for many patients, but only a fe
Autor:
Julia Deri, Róbert Dóczi, Barbara Vodicska, Dora Tihanyi, István Peták, István Vályi-Nagy, Judita Szkukalek, Anna Dirner, Dóra Lakatos, Ákos Boldizsár, Zsuzsanna Nagy, Edit Várkondi, Ágnes Varga, Richard Schwab, Gábor Pajkos, Dorottya Valtinyi
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 1850, p 1850 (2021)
Diagnostics, Vol 11, Iss 1850, p 1850 (2021)
Background: We present the case of a 50-year-old female whose metastatic pancreatic neuroendocrine tumor (pNET) diagnosis was delayed by the COVID-19 pandemic. The patient was in critical condition at the time of diagnosis due to the extensive tumor
Autor:
István Peták, Julia Deri, Judit Kocsis, Ingrid Balogh, Edit Béres, Zsolt Horváth, Csilla András, Anita Árokszállási, Levente Jánváry
Publikováno v:
Journal of Gastrointestinal Oncology. 8:E32-E38
Since the prognosis of advanced cholangiocarcinoma (CCA) remains poor with traditional chemotherapy, attention has shifted to molecularly targeted agents. Results of available clinical studies reveal little or no benefit of using targeted agents in a
Autor:
Dóra Mathiász, István Peták, Edit Várkondi, Agnes Maczak-Gyongy, Eszter Kanta, Csilla Hegedüs, István Vályi-Nagy, Richard Schwab, Julia Deri
Publikováno v:
Journal of Clinical Oncology. 36:e24300-e24300
e24300Background: Relevance of hereditary BRCA mutations is well-known in breast and ovarian cancer and is also emerging in other solid tumors. Most databases provide BRCA classification on a genet...
Autor:
Nancy Feldman, Deborah J. MacDonald, Benjamin Paz, Charité Ricker, Lori Viveros, Julia Deri, Kathleen R. Blazer, Martin A. Perez, Raquel Ogaz, Jeffrey N. Weitzel
A patient/family-centered conference was conducted at an underserved community hospital to address Latinas’ post-genetic cancer risk assessment (GCRA) medical information and psychosocial support needs, and determine the utility of the action resea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea824e8f802f525d23fac963c4d7043
https://europepmc.org/articles/PMC3620038/
https://europepmc.org/articles/PMC3620038/
Autor:
Deborah J. MacDonald, Julia Deri, Charité Ricker, Martin A. Perez, Raquel Ogaz, Nancy Feldman, Lori A. Viveros, Benjamin Paz, Jeffrey N. Weitzel, Kathleen R. Blazer
Publikováno v:
Familial Cancer. 12:585-585
Autor:
Judita Szkukalek, Róbert Dóczi, Anna Dirner, Ákos Boldizsár, Ágnes Varga, Júlia Déri, Dóra Lakatos, Dóra Tihanyi, Barbara Vodicska, Richárd Schwáb, Gábor Pajkos, Edit Várkondi, István Vályi-Nagy, Dorottya Valtinyi, Zsuzsanna Nagy, István Peták
Publikováno v:
Diagnostics, Vol 11, Iss 10, p 1850 (2021)
Background: We present the case of a 50-year-old female whose metastatic pancreatic neuroendocrine tumor (pNET) diagnosis was delayed by the COVID-19 pandemic. The patient was in critical condition at the time of diagnosis due to the extensive tumor
Externí odkaz:
https://doaj.org/article/7ab3b8fd1ec74cd3a1932c4cb7cb1cdb